Table 1.
Arterial systolic, diastolic, and mean arterial pressures (MAP) and Heart Rate from control and experimental groups. UTII − 4 week administration of urotensin II; VO − 4 week volume overload; VO+UTII − 4 week VO + 4 week UTII administration (Data are reported as mean ± sem with n = 8 in all groups)
| Groups |
Systolic (mmHg) |
Diastolic (mmHg) |
MAP (mmHg) |
Heart Rate (Beats/minute) |
|---|---|---|---|---|
| Control | 117.6 ± 4.5 | 70.3 ± 8.3 | 86.1 ± 6.6 | 314 ± 25 |
| UTII | 103.6 ± 6.7* | 83.0 ± 6.7 | 89.9 ± 6.5$ | 335 ± 14 |
| VO | 83.5 ± 3.4*†# | 56.2 ± 8.3 | 65.3 ± 6.6*† | 326 ± 16 |
| VO+UTII | 100.0 ± 3.1* | 62.0 ± 1.3 | 74.7 ± 1.5 | 341 ± 21 |
p<0.05 vs. Control
p<0.05 vs. VO+UTII
p<0.05 vs. UTII
p<0.05 vs. VO